Holen Sie sich die Stockscreener-App
76.82
2.62%
-2.07
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MET?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$78.89
Offen:
$79.04
24-Stunden-Volumen:
1.32M
Relative Volume:
0.36
Marktkapitalisierung:
$50.35B
Einnahmen:
$77.08B
Nettoeinkommen (Verlust:
$3.40B
KGV:
16.31
EPS:
4.711
Netto-Cashflow:
$15.15B
1W Leistung:
+1.99%
1M Leistung:
-1.91%
6M Leistung:
+0.34%
1J Leistung:
-7.14%
1-Tages-Spanne:
$76.27
$79.60
1-Wochen-Bereich:
$75.63
$79.60
52-Wochen-Spanne:
$65.21
$87.39
Metlife Inc Stock (MET) Company Profile
Firmenname
Metlife Inc
Sektor
Branche
Telefon
212-578-5500
Adresse
200 PARK AVENUE, NEW YORK, NY
Compare MET vs AFL, MFC, PUK, PRU
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MET
Metlife Inc
|
76.84 | 51.70B | 77.08B | 3.40B | 15.15B | 4.711 |
|
AFL
Aflac Inc
|
116.50 | 60.30B | 17.13B | 3.65B | 2.57B | 6.8862 |
|
MFC
Manulife Financial Corp
|
35.87 | 63.53B | 42.06B | 4.30B | 21.81B | 2.2533 |
|
PUK
Prudential Plc Adr
|
29.82 | 40.46B | 21.69B | 3.60B | 1.36B | 2.5833 |
|
PRU
Prudential Financial Inc
|
103.58 | 36.83B | 57.61B | 2.86B | 5.27B | 7.2959 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-16 | Eingeleitet | Mizuho | Outperform |
| 2025-09-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-09-16 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-23 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2024-10-09 | Eingeleitet | TD Cowen | Buy |
| 2024-09-05 | Eingeleitet | Barclays | Overweight |
| 2024-01-08 | Hochstufung | Goldman | Neutral → Buy |
| 2023-11-17 | Fortgesetzt | Barclays | Overweight |
| 2023-10-05 | Eingeleitet | Deutsche Bank | Hold |
| 2023-09-14 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-09 | Herabstufung | Goldman | Buy → Neutral |
| 2022-12-09 | Herabstufung | Jefferies | Buy → Hold |
| 2022-09-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-06-23 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-05-24 | Eingeleitet | Citigroup | Buy |
| 2022-01-26 | Eingeleitet | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-01-12 | Bestätigt | UBS | Buy |
| 2022-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-04-21 | Eingeleitet | UBS | Buy |
| 2021-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-17 | Eingeleitet | Barclays | Overweight |
| 2020-06-01 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-03-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-07-16 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-03-19 | Herabstufung | Sandler O'Neill | Buy → Hold |
| 2019-01-16 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-01-02 | Hochstufung | Sandler O'Neill | Hold → Buy |
| 2018-06-04 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-25 | Eingeleitet | Credit Suisse | Outperform |
| 2018-03-26 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-01-02 | Eingeleitet | Deutsche Bank | Hold |
| 2017-11-10 | Herabstufung | Sandler O'Neill | Buy → Hold |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-05-25 | Hochstufung | FBR & Co. | Mkt Perform → Outperform |
| 2017-03-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-01-26 | Eingeleitet | Citigroup | Sell |
| 2016-12-09 | Herabstufung | Standpoint Research | Buy → Hold |
Alle ansehen
Metlife Inc Aktie (MET) Neueste Nachrichten
Mizuho Adjusts Price Target on MetLife to $100 From $102, Maintains Outperform Rating - marketscreener.com
ProShare Advisors LLC Sells 13,189 Shares of MetLife, Inc. $MET - MarketBeat
Critical Illness Insurance Market to Reach USD 659.84 Billion by 2033, Growing at 9.01% CAGR – SNS Insider - GlobeNewswire Inc.
Evercore ISI Adjusts Price Target for MetLife (MET) as In-Line R - GuruFocus
Evercore ISI Adjusts Price Target on MetLife to $95 From $97, Maintains In Line Rating - marketscreener.com
The Bull Case For MetLife (MET) Could Change Following Rising Revenue, Falling Earnings And Ongoing Buybacks - simplywall.st
5 Insightful Analyst Questions From MetLife's Q4 Earnings Call - Finviz
Precision Trading with Metlife Inc. (MET) Risk Zones - Stock Traders Daily
Candriam S.C.A. Sells 193,802 Shares of MetLife, Inc. $MET - MarketBeat
MetLife price target lowered to $95 from $97 at Evercore ISI - Investing.com India
Evercore ISI Cuts MetLife Price Target to $95 From $97 - marketscreener.com
Metlife study finds less than half of US workforce holistically healthy - InsuranceNewsNet
Half of Retirees Fear Running Out of Money as Pressures on U.S. Retirement Security Intensify, MetLife Research Finds - Business Wire
Compagnie Lombard Odier SCmA Has $13.57 Million Stock Position in MetLife, Inc. $MET - MarketBeat
Providence Capital Advisors LLC Takes Position in MetLife, Inc. $MET - MarketBeat
Versor Investments LP Lowers Holdings in MetLife, Inc. $MET - MarketBeat
Signature Estate & Investment Advisors LLC Has $876,000 Stock Holdings in MetLife, Inc. $MET - MarketBeat
MetLife, Inc. $MET Stock Position Decreased by Applied Finance Capital Management LLC - MarketBeat
5 Insightful Analyst Questions From MetLife’s Q4 Earnings Call - The Globe and Mail
MetLife Slips 3% This Week: Here’s Why Analysts Still Sees $104.83 Fair Value - TIKR.com
Jefferies Adjusts MetLife Price Target to $96 From $101, Maintains Buy Rating - marketscreener.com
MetLife UK pays out £252mn in employee benefits - FT Adviser
Risk Recap: Is MetLife Inc a momentum stockMarket Sentiment Summary & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Diamond Hill Capital Management Inc. Has $329.62 Million Position in MetLife, Inc. $MET - MarketBeat
Metlife (MET) Gets a Buy from Barclays - The Globe and Mail
MetLife Stock: Limited Upside Given VII Reliance (NYSE:MET) - Seeking Alpha
MetLife, Inc. (NYSE:MET) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MetLife Q4 Earnings Call Highlights - MarketBeat
MetLife, Inc. (NYSE:MET) Q4 2025 Earnings Call Transcript - Insider Monkey
Research Alert: CFRA Keeps Buy Opinion On Shares Of Metlife, Inc. - 富途牛牛
‘There’s no demand for labor’ – MetLife’s Drew Matus - Seeking Alpha
MetLife stock outlook: Is Wall Street bullish or bearish? - MSN
Piper Sandler Adjusts Price Target on MetLife to $81 From $84, Maintains Neutral Rating - marketscreener.com
Wolfe Research Adjusts Price Target on MetLife to $89 From $91, Maintains Outperform Rating - marketscreener.com
MetLife Q4 2025 slides: Earnings exceed targets as investment management soars By Investing.com - Investing.com South Africa
Is MetLife Inc the Safest Flex on Wall Street Right Now? Real Talk on MET - AD HOC NEWS
MetLife Broadens Upwise Reach Through Nayya and Workday Deal - MSN
Envestnet Asset Management Inc. Sells 448,986 Shares of MetLife, Inc. $MET - MarketBeat
MetLife Reports Strong 2025 Results and Growth Momentum - The Globe and Mail
MetLife Inc (MET) Q4 2025 Earnings Call Highlights: Strong Finan - GuruFocus
MetLife Inc (MET) Q4 2025 Earnings Call Highlights: Strong Financial Performance and Strategic ... By GuruFocus - Investing.com Canada
6 Analysts Have This To Say About MetLife - Benzinga
MetLife Tops Fortune List As Investors Weigh Mixed Earnings Picture - Yahoo Finance
MetLife Q4 Earnings Beat Estimates on Increasing Volumes - Nasdaq
Barclays Adjusts Price Target on MetLife to $92 From $90, Maintains Overweight Rating - marketscreener.com
MetLife (MET) Reports Strong 2025 Earnings and Strategic Progres - GuruFocus
Earnings call transcript: MetLife Q4 2025 earnings beat EPS forecasts By Investing.com - Investing.com Nigeria
Higher Private Equity Returns Help Fuel MetLife Profit Jump - Bloomberg
UBS Adjusts Price Target on MetLife to $98 From $94, Maintains Buy Rating - marketscreener.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
MetLife Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Finanzdaten der Metlife Inc-Aktie (MET)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.67%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):